NEW YORK STATE COMMON RETIREMENT FUND
PensionPosition in ANTX — AN2 Therapeutics, Inc.
CIK 810265
ALBANY, NY
Position in ANTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$24,200
+$23,342 QoQ
Shares Held
5,000
+4850.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 66 holders
Holding Since
Jun 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEW YORK STATE COMMON RETIREMENT FUND holds $953,600,073 across 287 Biotechnology names. ANTX ranks #275 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
277,614 | $137,899,202 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
111,369 | $69,443,026 | |
| 3 | ASND |
Ascendis Pharma A/S
|
191,791 | $51,154,495 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
94,743 | $50,872,253 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
137,258 | $43,385,881 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
500,050 | $39,648,964 | |
| 7 | INSM |
INSMED Inc
|
304,236 | $32,437,642 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
250,558 | $29,332,825 |
All Filings in ANTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,200 | 5,000 | Shares | Sole | 2026-07-29 | |
| 2023-06-30 | $858 | 101 | Shares | Sole | 2025-10-08 | |
| 2023-03-31 | $58,025 | 5,879 | Shares | Sole | 2025-10-08 | |
| 2022-12-31 | $55,512 | 5,825 | Shares | Sole | 2025-10-08 | |
| 2022-09-30 | $101,238 | 5,825 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $88,350 | 11,400 | Shares | Sole | 2022-08-04 | |
| No filing history on record for this holder in this stock. | ||||||